Cargando…

Characteristics of Pivotal Trials and FDA Review of Innovative Devices

When patients lack sufficient treatment options for serious medical conditions, they rely on the prompt approval and development of new therapeutic alternatives, such as medical devices. Understanding the development of innovative medical devices, including the characteristics of premarket clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rising, Joshua P., Moscovitch, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317185/ https://www.ncbi.nlm.nih.gov/pubmed/25651420 http://dx.doi.org/10.1371/journal.pone.0117235

Ejemplares similares

Characteristics of pivotal clinical trials of FDA-approved endovascular devices between 2000 and 2018: An interrupted time series analysis
por: Moon, John T., et al.
Publicado: (2023)

Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA
por: Swanson, Matthew J., et al.
Publicado: (2021)

Data visualization explorer: A tool for participant representation in pivotal trials of FDA-approved medicinal products
por: Carmeli, Ariel B., et al.
Publicado: (2023)

FDA oversight of medical devices
por: Hill, Matthew W, et al.
Publicado: (2012)

Comparison of treatment effect sizes from pivotal and postapproval trials of novel therapeutics approved by the FDA based on surrogate markers of disease: a meta-epidemiological study
por: Wallach, Joshua D., et al.
Publicado: (2018)

OpenFDA: an innovative platform providing access to a wealth of FDA’s publicly available data
por: Kass-Hout, Taha A, et al.
Publicado: (2016)

Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016)

Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process
por: Heneghan, Carl J, et al.
Publicado: (2017)

Review of the Processes for FDA Oversight of Drugs, Medical Devices, and Combination Products
por: Sweet, Burgunda V., et al.
Publicado: (2011)

Advancing digital health: FDA innovation during COVID-19
por: Kadakia, Kushal, et al.
Publicado: (2020)

The power of public–private partnership in medical technology innovation: Lessons from the development of FDA-cleared medical devices for assessment of concussion
por: Singer, Michael E., et al.
Publicado: (2022)

The innovation in computing companion: a compendium of select, pivotal inventions
por: O'Regan, Gerard
Publicado: (2018)

Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir
por: Singh, Ravi Shankar P., et al.
Publicado: (2022)

Security and Privacy Qualities of Medical Devices: An Analysis of FDA Postmarket Surveillance
por: Kramer, Daniel B., et al.
Publicado: (2012)

Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs
por: Golish, S. Raymond
Publicado: (2017)

Quantitative analysis on the characteristics of targets with FDA approved drugs
por: Sakharkar, Meena K., et al.
Publicado: (2007)

Voting behavior during FDA Medical Device Advisory Committee panel meetings
por: Maisel-Campbell, Amanda, et al.
Publicado: (2022)

Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs
por: Van Norman, Gail A.
Publicado: (2016)

Cybersecurity features of digital medical devices: an analysis of FDA product summaries
por: Stern, Ariel Dora, et al.
Publicado: (2019)

Pivotal clinical trials of novel ophthalmic drugs and medical devices: retrospective observational study, 2002–2012
por: Hwang, Jenny, et al.
Publicado: (2015)

Inclusion of patient-reported outcome instruments in US FDA medical device marketing authorizations
por: Matts, Sophia T., et al.
Publicado: (2022)

US FDA Drug Approvals are Persistent and Polycyclic: Insights into Economic Cycles, Innovation Dynamics, and National Policy
por: Daizadeh, Iraj
Publicado: (2021)

Reporter’s occupation and source of adverse device event reports contained in the FDA’s MAUDE database
por: Kavanagh, Kevin T, et al.
Publicado: (2019)

The FDA-Approved Essure Device Counseling Order Fails to Promote Patient Empowerment
por: Gunn, Christine M., et al.
Publicado: (2019)

Recall Rates of Total Knee Arthroplasty Devices Are Dependent on the FDA Approval Process
por: Pellerin, Carl, et al.
Publicado: (2020)

Menstrual tampons and vaginal pessaries: regulation of intravaginal medical devices by the US FDA
por: Pollard, Colin M.
Publicado: (2023)

Rediscovering FDA Websites
por: Navarro, Robert P.
Publicado: (2012)

FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine
por: Luh, Frank, et al.
Publicado: (2018)

PAs as principal investigators of FDA-regulated clinical trials
por: Nalepinski, Colleen Elizabeth Gosa
Publicado: (2023)

The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database
por: Benjamens, Stan, et al.
Publicado: (2020)

Pivot Teeth
por: Steel, Charles L.
Publicado: (1881)

Pivot Teeth
por: Bean, James B.
Publicado: (1869)

Pivot Teeth
por: Hunter, F. L.
Publicado: (1873)

Pivot Teeth
por: Taft, J.
Publicado: (1851)

Antiseptic efficacy of an innovative perioperative surgical skin preparation: A confirmatory FDA phase 3 analysis
por: Edmiston, Charles E., et al.
Publicado: (2020)

The FDA’s standard-making process for medical digital health technologies: co-producing technological and organizational innovation
por: Lievevrouw, Elisa, et al.
Publicado: (2021)

Pivot Teeth
Publicado: (1869)

Pivoting Teeth
por: Coghlan, John
Publicado: (1856)

Petitioning the FDA to Improve Pharmaceutical, Device and Public Health Safety by Ordinary Citizens: A Descriptive Analysis
por: Chen, Brian K., et al.
Publicado: (2016)

An innovative approach for the evaluation of prolonged disorders of consciousness using NF-L and GFAP biomarkers: a pivotal study
por: Coppola, L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_luv0en6hq9ga0ge679uo86v1on